Digang, Merlina D.

HRN: 05-24-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/08/2022
06/14/2022
IV
4.5 G
Q6H
Methimazole-Induced Agranulocytosis; Febrile Neutropenia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Febrile Neutropenia    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: